A NITI Aayog report states Ayurveda has global potential for holistic care but needs scientific validation, regulatory reforms, and standardisation to compete internationally.

A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...

InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...

Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with Nuvectis, a U.S. biotechnology company. Under the agreement, Haisco ...

A new kind of partnership between human and machine is beginning to reshape how stroke recovery may look in the future.

India’s agricultural transformation will come from combining farmer wisdom, scientific knowledge, digital public ...

CAMBRIDGE, Mass., July 2, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, today ...

For families facing a pediatric brain or spine condition, access to specialized care can make all the difference. At Driscoll ...

Cemdisiran could be the first siRNA approved for the treatment of gMG and only therapy to be offered subcutaneously with four times a year dosing ...

Summary: Patients surviving severe traumatic brain injuries often enter states designated as Prolonged Disorders of ...

In 1939, he repeatedly placed dog ticks on guinea pigs and watched something change. After the first round of bites, the ...